Patterns of Use and Discontinuation of Secondary Prevention Medications After Stroke.

Lachlan L Dalli Joosup Kim Amanda G Thrift Nadine E Andrew Frank M Sanfilippo Derrick Lopez Rohan S Grimley Natasha A Lannin Lillian Wong Richard I Lindley Bruce C V Campbell Craig S Anderson Dominique Ann-Michele Cadilhac Monique F Kilkennynull null

Published in: Neurology (2020)

Patterns of use of secondary prevention medications after stroke/TIA are not optimal, with many survivors discontinuing treatment within 1 year postdischarge. Improving postdischarge care for patients with stroke/TIA is needed to minimize unwarranted discontinuation.

Keyphrases

healthcare
atrial fibrillation
palliative care
young adults
brain injury
blood brain barrier
cerebral ischemia